AINA OLUWO: Open Payments
NPI 1508644253 · WALDORF, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$239 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $239
Food & beverage: $239
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $100 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Lundbeck LLC | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
Products named: ARISTADA, REXULTI, JARDIANCE, ABILIFY ASIMTUFII, FARXIGA, CAPLYTA.
Industry payments across MD — which companies pay providers there.
